Want to see IN:ANTHEM full AI Analyst Report?

Anthem Biosciences Limited (ANTHEM) Ratios

5 Followers

Anthem Biosciences Limited Ratios

IN:ANTHEM's free cash flow for Q2 2025 was ₹0.59. For the 2025 fiscal year, IN:ANTHEM's free cash flow was decreased by ₹ and operating cash flow was ₹0.42. See a summary of the company’s cash flow.

Ratios	TTM	Mar 26	Mar 25	Mar 24	Mar 23
Liquidity Ratios
Current Ratio	5.54	5.54	5.32	―	―
Quick Ratio	5.15	5.15	4.28	―	―
Cash Ratio	0.84	0.84	0.97	―	―
Solvency Ratio	1.84	1.88	1.36	―	―
Operating Cash Flow Ratio	1.24	2.81	1.28	―	―
Short-Term Operating Cash Flow Coverage	17.25	39.29	6.76	―	―
Net Current Asset Value	₹ 14.16B	₹ 14.16B	₹ 13.39B	₹ ―	₹ ―
Leverage Ratios
Debt-to-Assets Ratio	0.02	0.02	0.04	―	―
Debt-to-Equity Ratio	0.02	0.02	0.05	―	―
Debt-to-Capital Ratio	0.02	0.02	0.04	―	―
Long-Term Debt-to-Capital Ratio	<0.01	<0.01	0.02	―	―
Financial Leverage Ratio	1.13	1.13	1.17	―	―
Debt Service Coverage Ratio	21.78	19.89	7.65	―	―
Interest Coverage Ratio	106.20	101.50	59.12	―	―
Debt to Market Cap	<0.01	<0.01	<0.01	―	―
Interest Debt Per Share	1.07	1.08	2.20	―	―
Net Debt to EBITDA	-0.26	-0.26	-0.27	―	―
Profitability Margins
Gross Profit Margin	47.39%	42.14%	59.67%	―	―
EBIT Margin	35.54%	32.94%	36.15%	―	―
EBITDA Margin	42.41%	39.25%	41.00%	―	―
Operating Profit Margin	32.73%	32.94%	32.10%	―	―
Pretax Profit Margin	39.08%	38.80%	35.61%	―	―
Net Profit Margin	28.76%	27.86%	24.46%	―	―
Continuous Operations Profit Margin	28.76%	27.86%	24.46%	―	―
Net Income Per EBT	73.60%	71.80%	68.70%	―	―
EBT Per EBIT	119.43%	117.79%	110.93%	―	―
Return on Assets (ROA)	16.79%	17.26%	16.07%	―	―
Return on Equity (ROE)	19.88%	19.45%	18.73%	―	―
Return on Capital Employed (ROCE)	21.11%	22.55%	23.86%	―	―
Return on Invested Capital (ROIC)	15.41%	16.06%	15.99%	―	―
Return on Tangible Assets	16.80%	17.26%	16.10%	―	―
Earnings Yield	1.19%	1.61%	1.10%	―	―
Efficiency Ratios
Receivables Turnover	3.39	3.60	4.01	―	―
Payables Turnover	14.01	16.34	6.42	―	―
Inventory Turnover	8.46	9.87	2.19	―	―
Fixed Asset Turnover	1.91	2.03	1.83	―	―
Asset Turnover	0.58	0.62	0.66	―	―
Working Capital Turnover Ratio	1.25	1.47	1.44	―	―
Cash Conversion Cycle	124.74	116.11	201.16	―	―
Days of Sales Outstanding	107.66	101.47	91.01	―	―
Days of Inventory Outstanding	43.14	36.98	167.03	―	―
Days of Payables Outstanding	26.06	22.34	56.88	―	―
Operating Cycle	150.80	138.45	258.04	―	―
Cash Flow Ratios
Operating Cash Flow Per Share	7.15	16.35	7.45	―	―
Free Cash Flow Per Share	4.88	12.58	1.85	―	―
CapEx Per Share	2.27	3.76	5.60	―	―
Free Cash Flow to Operating Cash Flow	0.68	0.77	0.25	―	―
Dividend Paid and CapEx Coverage Ratio	3.15	4.34	1.33	―	―
Capital Expenditure Coverage Ratio	3.15	4.34	1.33	―	―
Operating Cash Flow Coverage Ratio	7.46	17.00	3.69	―	―
Operating Cash Flow to Sales Ratio	0.20	0.43	0.23	―	―
Free Cash Flow Yield	0.57%	1.92%	0.25%	―	―
Valuation Ratios
Price-to-Earnings (P/E) Ratio	83.76	62.21	90.84	―	―
Price-to-Sales (P/S) Ratio	24.08	17.33	22.24	―	―
Price-to-Book (P/B) Ratio	15.89	12.10	17.02	―	―
Price-to-Free Cash Flow (P/FCF) Ratio	175.46	52.17	395.66	―	―
Price-to-Operating Cash Flow Ratio	120.10	40.15	98.05	―	―
Price-to-Earnings Growth (PEG) Ratio	6.03	1.99	3.96	―	―
Price-to-Fair Value	15.89	12.10	17.02	―	―
Enterprise Value Multiple	56.52	43.89	53.97	―	―
Enterprise Value	480.02B	365.94B	408.14B	―	―
EV to EBITDA	56.52	43.89	53.97	―	―
EV to Sales	23.97	17.23	22.13	―	―
EV to Free Cash Flow	174.65	51.85	393.71	―	―
EV to Operating Cash Flow	119.26	39.91	97.56	―	―
Tangible Book Value Per Share	54.02	54.23	42.84	―	―
Shareholders’ Equity Per Share	54.03	54.24	42.91	―	―
Tax and Other Ratios
Effective Tax Rate	0.26	0.28	0.31	―	―
Revenue Per Share	35.56	37.87	32.84	―	―
Net Income Per Share	10.23	10.55	8.04	―	―
Tax Burden	0.74	0.72	0.69	―	―
Interest Burden	1.10	1.18	0.98	―	―
Research & Development to Revenue	0.00	0.00	0.01	―	―
SG&A to Revenue	0.08	0.09	<0.01	―	―
Stock-Based Compensation to Revenue	<0.01	<0.01	0.02	―	―
Income Quality	1.30	1.55	0.64	―	―

Currency in INR